Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	45,308	30,350	24,021	29,238	20,282	15,100
Market Cap Growth	40.99%	26.35%	-17.84%	44.16%	34.32%	17.60%
Enterprise Value	44,850	30,296	24,278	29,564	19,873	14,639
Last Close Price	339.11	235.31	191.41	237.65	169.58	129.97
PS Ratio	13.76	13.50	13.14	28.18	24.02	30.64
PB Ratio	191.08	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	191.54	452.40	-	-	34.48	14.86
P/FCF Ratio	202.39	-	572.67	-	-	-
P/OCF Ratio	168.51	-	230.62	-	-	-
EV/Sales Ratio	13.97	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	202.61	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.10%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.49%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q